Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03624309
Brief Title: Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer

First Submitted : August 5, 2018
First Submitted that Met QC Criteria : August 9, 2018
First Posted : August 10, 2018

Last Update Submitted that Met QC Criteria : September 13, 2018
Last Update Posted : September 17, 2018